comprehensive -WSS

comprehensive

author：leisure time 2025-09-30 11:45:47 Page View：684

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： A disappointing year of Humira biosimilars
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

comprehensive

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

What should King Charles tell the public about his cancer?

AphotoillustrationshowingaselectionoffrontpagescoveringthenewsofKingCharlesbeingdiagnosedwithanunspe

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Microsoft's Peter Lee: Generative AI could help doctors be more human

AlexHogan/STATGenerativeAIishavingamoment.PeterLee,whooverseesMicrosoft’sapproachtohealthcareandco-a

comprehensive

explore

comprehensive

Microsoft's Peter Lee: Generative AI could help doctors be more human